| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V75174 | (±)11(12)-EET-d11 ((±)11,12-EET-d11) | 2699607-19-5 | (±)11(12)-EET-d11 is the deuterated form of (±)11(12)-EET. |
|
V85981 | Callicarboric acid A | ||
|
V83500 | COX-2/NLRP3-IN-1 | ||
|
V74293 | D359-0396 | 1031977-31-7 | D359-0396 is an orally bioactive NLRP3 inflammasome inhibitor. |
|
V118745 | Human NLRP3 mRNA | Human NLRP3 mRNA encodes the NLRP3 protein, an inflammasome. | |
|
V117364 | IIIM-1270 | 4818-19-3 | IIIM-1270 is an NLRP3 inflammasome inhibitor. |
|
V2031 | INF39 | 866028-26-4 | INF39 (INF-39; INF 39), an acrylate derivative, is a potent, irreversible andnontoxic inhibitor of NLRP3 with potential anti-inflammatory activity. |
|
V75180 | JT002 | 2238820-43-2 | JT002 is an orally bioactive NLRP3 inflammasome inhibitor. |
|
V86935 | MC-ND-18 | MC-ND-18 is a degrader of NLRP3 via autophagy, with a DC50 of 125.5 nM in THP-1 cells. | |
|
V75162 | NLRP3-IN-13 | 1704638-35-6 | NLRP3-IN-13 (referred to as compound C77 in the patent) is a potent and specific NLRP3 inhibitor (IC50= 2.1 μM). |
|
V85836 | NLRP3-IN-26 | 2927413-30-5 | |
|
V100280 | NLRP3-IN-34 | 1392502-55-4 | NLRP3-IN-34 (compound T10) is an inhibitor of NLRP3 inflammasome. |
|
V103930 | NLRP3-IN-35 | NLRP3-IN-35 (Compound 11) is a NLRP3 inhibitor (IC50 < 1 μM). | |
|
V86930 | NLRP3-IN-42 | NLRP3-IN-42 (compound H28) is a potent NLRP3 inhibitor with a KD of 1.15 µM. | |
|
V94392 | NLRP3-IN-54 | NLRP3-IN-54 (Compound C4) is a NLRP3 inhibitor. | |
|
V94338 | NLRP3-IN-56 | 3048421-42-4 | NLRP3-IN-56 (Compound 062) is a NLRP3 inhibitor. |
|
V51066 | NLRP3/AIM2-IN-2 | 791840-86-3 | NLRP3/AIM2-IN-2 is a new and potent analogue targeting NLRP3 and AIM2 key body-dependent pyroptosis with different species topology. |
|
V104925 | NP3-253 | 2557349-50-3 | NP3-253 is an orally active and blood-brain barrier-permeable NLRP3 inhibitor that can be used as a tool to further explore the biology of NLRP3 in peripheral and neuroinflammatory models. |
|
V115435 | NP3-742 | NP3-742 is an orally effective NLRP3 inhibitor that binds to the NACHT domain of NLRP3. | |
|
V86917 | NT-0249 free base | NT-0249 free base is an orally active NLRP3 inhibitor. |